42 development-"https:"-"https:"-"https:"-"CentraleSupélec" Fellowship positions at University of British Columbia
Sort by
Refine Your Search
-
Mitacs Elevate is a postdoctoral fellowship with an exclusive professional development curriculum component. Fellows address complex challenges through: A two-year research project with a partner
-
on the development of nanomedicine and gene therapy against chronic diseases and these specific aims to develop novel cancer nanomedicine using gene therapy to deliver functional proteins that tackle the dense
-
. Supported by Alberta Innovates , Alberta Ministry of Jobs, Economy and Northern Development , Calgary Economic Development’s Opportunity Calgary Investment Fund and Western Economic Diversification
-
research environments that will have maximal impact on their future scientific development. There are two options for awardees: Research Fellowship and Research Instructorship. Awards will support research
-
hybrid work agreement. The salary range for this position is $65,000 - $75,000 per annum, plus benefits. The primary goal of the CMMI is to develop an integrated multi ‘omics platform to investigate
-
position to launch independent careers. Collaborations with the University of California San Francisco (UCSF) further expand the opportunities for professional and career development. NOMIS–Gladstone Fellows
-
at the UBC Vancouver campus with the possibility of a hybrid work agreement. The salary range for this position is $65,000 - $75,000 per annum, plus benefits. The primary goal of the CMMI is to develop
-
Translating basic science discoveries into practice Improving techniques to measure pain Developing new and more personalized treatment approaches Alternative approaches to pain management including research
-
(CEDRN). This role will focus on developing and piloting ED-based surveillance methods, generating high-quality data to inform public health decision-making, and advancing national capacity for future
-
Rationally (PROGENITER), which aims to design novel antibody-based therapeutics against emerging pathogens with the goal of building products and capacity to prepare for the next pandemic. The candidate is